CPHI vs SPCE · rev $4.1M vs rev $7.0M
China Pharma Holdings Inc (CPHI) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
CPHI currently screens at market cap $29.0M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the CPHI and SPCE stock pages for the full models.
Not investment advice.